Open source Jul 21, 2026 Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Open source 4 Min Read Benchmark raises its first-ever growth fund as part of $2B capital raise By Editorial Team June 4, 2026 Read Article
Open source 6 Min Read Cerebras IPO makes billions for Benchmark but VC Eric Vishria almost didn’t take the meeting By Editorial Team May 14, 2026 Read Article
